This project has two purposes. As the statistics core, the project will provide statistical support to other superfund projects. This will typically involve assistance in experimental design or in the analysis and interpretation of data. In addition, this project proposes the development and refinement of statistical methods and algorithms for the analysis of toxics measurement data and for the creation of new and improved measurement techniques. Many analytical methods can be made more efficient and effective by careful statistical design and analysis of the data. This may be important to human health since it allows more frequent monitoring of hazardous sites for the same cost, and since it aids in the development and use of analytical techniques to detect toxic substances both clinically and in the field at lower levels and with greater accuracy than existing methods. A particular emphasis is on statistical contributions to the development of improved ELISA protocols and to the better analysis of data from existing protocols. Techniques such as empirical Bayes estimation, nonlinear optimal design, maximum pseudo-likelihood, and M-estimation will allow these methods to deal with complex problems of nonlinear calibration, nonconstant variance, possible outliers, and values near or below detection limits.
Specific Aims I. Develop and test new and improved statistical methodologies addressing statistical problems typically encountered in the analysis of toxics measurement data using ELISA and other analytical methods. II. Apply state-of-the-art techniques in numerical analysis and numerical optimization to develop efficient, fast, and reliable computer algorithms to solve problems in implementing statistical methods from I. III. Collaborate with other Superfund projects on statistical and mathematical problems of importance to those projects. Test and validate the methods and algorithms derived from I and II using data from other projects. Specific current collaborations are with Hammock's immunochemical project and with Jones's analytical core. IV. Develop software that incorporates the developments in statistical methodology and numerical methods that arise from this project so that they can be used by other scientists in a laboratory setting.

Project Start
Project End
Budget Start
Budget End
Support Year
6
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of California Davis
Department
Type
DUNS #
094878337
City
Davis
State
CA
Country
United States
Zip Code
95618
Hill 3rd, Thomas; Rice, Robert H (2018) DUOX expression in human keratinocytes and bronchial epithelial cells: Influence of vanadate. Toxicol In Vitro 46:257-264
Taha, Ameer Y; Hennebelle, Marie; Yang, Jun et al. (2018) Regulation of rat plasma and cerebral cortex oxylipin concentrations with increasing levels of dietary linoleic acid. Prostaglandins Leukot Essent Fatty Acids 138:71-80
Kodani, Sean D; Wan, Debin; Wagner, Karen M et al. (2018) Design and Potency of Dual Soluble Epoxide Hydrolase/Fatty Acid Amide Hydrolase Inhibitors. ACS Omega 3:14076-14086
Ren, Qian; Ma, Min; Yang, Jun et al. (2018) Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson's disease. Proc Natl Acad Sci U S A 115:E5815-E5823
Pecic, Stevan; Zeki, Amir A; Xu, Xiaoming et al. (2018) Novel piperidine-derived amide sEH inhibitors as mediators of lipid metabolism with improved stability. Prostaglandins Other Lipid Mediat 136:90-95
Yamanashi, Haruto; Boeglin, William E; Morisseau, Christophe et al. (2018) Catalytic activities of mammalian epoxide hydrolases with cis and trans fatty acid epoxides relevant to skin barrier function. J Lipid Res 59:684-695
Wang, Fuli; Zhang, Hongyong; Ma, Ai-Hong et al. (2018) COX-2/sEH Dual Inhibitor PTUPB Potentiates the Antitumor Efficacy of Cisplatin. Mol Cancer Ther 17:474-483
Napimoga, M H; Rocha, E P; Trindade-da-Silva, C A et al. (2018) Soluble epoxide hydrolase inhibitor promotes immunomodulation to inhibit bone resorption. J Periodontal Res 53:743-749
Blöcher, René; Wagner, Karen M; Gopireddy, Raghavender R et al. (2018) Orally Available Soluble Epoxide Hydrolase/Phosphodiesterase 4 Dual Inhibitor Treats Inflammatory Pain. J Med Chem 61:3541-3550
Hao, Lei; Kearns, Jamie; Scott, Sheyenne et al. (2018) Indomethacin Enhances Brown Fat Activity. J Pharmacol Exp Ther 365:467-475

Showing the most recent 10 out of 1149 publications